In the past week, ZURA stock has gone up by 33.33%, with a monthly gain of 11.11% and a quarterly surge of 21.74%. The volatility ratio for the week is 8.71%, and the volatility levels for the last 30 days are 8.48% for Zura Bio Ltd The simple moving average for the last 20 days is 20.17% for ZURA stock, with a simple moving average of -35.88% for the last 200 days.
Is It Worth Investing in Zura Bio Ltd (NASDAQ: ZURA) Right Now?
Additionally, the 36-month beta value for ZURA is -0.11. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for ZURA is 38.63M and currently, short sellers hold a 6.91% ratio of that float. The average trading volume of ZURA on July 09, 2025 was 552.41K shares.
ZURA) stock’s latest price update
The stock of Zura Bio Ltd (NASDAQ: ZURA) has increased by 16.67% when compared to last closing price of $1.2. Despite this, the company has experienced a 33.33% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-07-01 that HENDERSON, Nev.–(BUSINESS WIRE)—- $ZURA #TeamZura–Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases, today announced the appointment of Eric Hyllengren as Chief Financial Officer, effective July 7, 2025. He will succeed Verender Badial, who will step down from the role and remain with the company as a non-executive employee through July 31, 2025, to support a seamless transi.
Analysts’ Opinion of ZURA
Many brokerage firms have already submitted their reports for ZURA stocks, with Leerink Partners repeating the rating for ZURA by listing it as a “Outperform.” The predicted price for ZURA in the upcoming period, according to Leerink Partners is $15 based on the research report published on November 04, 2024 of the previous year 2024.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see ZURA reach a price target of $5. The rating they have provided for ZURA stocks is “Neutral” according to the report published on September 05th, 2024.
Piper Sandler gave a rating of “Overweight” to ZURA, setting the target price at $26 in the report published on May 03rd of the previous year.
ZURA Trading at 18.53% from the 50-Day Moving Average
After a stumble in the market that brought ZURA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.39% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZURA starting from Thiara Parvinder, who sale 1,001,633 shares at the price of $2.73 back on Nov 25 ’24. After this action, Thiara Parvinder now owns 0 shares of Zura Bio Ltd, valued at $2,734,458 using the latest closing price.
Thiara Parvinder, the Director of Zura Bio Ltd, sale 3,800,000 shares at $2.70 during a trade that took place back on Sep 11 ’24, which means that Thiara Parvinder is holding 1,001,633 shares at $10,260,000 based on the most recent closing price.
Stock Fundamentals for ZURA
Current profitability levels for the company are sitting at:
- -33032.0 for the present operating margin
The net margin for Zura Bio Ltd stands at -32217.5. The total capital return value is set at -0.44. Equity return is now at value -62.34, with -47.23 for asset returns.
Currently, EBITDA for the company is -52.39 million with net debt to EBITDA at 2.58. When we switch over and look at the enterprise to sales, we see a ratio of -43503.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.14.
Conclusion
In conclusion, Zura Bio Ltd (ZURA) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
